世界のオーロラキナーゼC市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV02736)
◆英語タイトル:Global Aurora Kinase C Market Insights and Forecast to 2026
◆商品コード:QYR20NV02736
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはオーロラキナーゼCの世界市場について調査・分析した資料です。種類別(AMG-900、Danusertib、Ilorasertib、NMI-900、SAR-156497、その他)の市場規模、用途別(固形腫瘍、非小細胞肺癌、急性リンパ性白血病、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別オーロラキナーゼCの競争状況、市場シェア
・世界のオーロラキナーゼC市場:種類別市場規模 2015年-2020年(AMG-900、Danusertib、Ilorasertib、NMI-900、SAR-156497、その他)
・世界のオーロラキナーゼC市場:種類別市場規模予測 2021年-2026年(AMG-900、Danusertib、Ilorasertib、NMI-900、SAR-156497、その他)
・世界のオーロラキナーゼC市場:用途別市場規模 2015年-2020年(固形腫瘍、非小細胞肺癌、急性リンパ性白血病、その他)
・世界のオーロラキナーゼC市場:用途別市場規模予測 2021年-2026年(固形腫瘍、非小細胞肺癌、急性リンパ性白血病、その他)
・北米のオーロラキナーゼC市場分析:米国、カナダ
・ヨーロッパのオーロラキナーゼC市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのオーロラキナーゼC市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のオーロラキナーゼC市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのオーロラキナーゼC市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AbbVie Inc、Amgen Inc、Cielo Therapeutics Inc、Sanofi
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Aurora Kinase C Market
The global Aurora Kinase C market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Aurora Kinase C Scope and Market Size
Aurora Kinase C market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aurora Kinase C market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Aurora Kinase C market is segmented into
AMG-900
Danusertib
Ilorasertib
NMI-900
SAR-156497
Others

Segment by Application, the Aurora Kinase C market is segmented into
Solid Tumor
Non-Small Cell Lung Cancer
Acute Lymphocytic Leukemia
Others

Regional and Country-level Analysis
The Aurora Kinase C market is analysed and market size information is provided by regions (countries).
The key regions covered in the Aurora Kinase C market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Aurora Kinase C Market Share Analysis
Aurora Kinase C market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Aurora Kinase C business, the date to enter into the Aurora Kinase C market, Aurora Kinase C product introduction, recent developments, etc.

The major vendors covered:
AbbVie Inc
Amgen Inc
Cielo Therapeutics Inc
Sanofi

【レポートの目次】

1 Study Coverage
1.1 Aurora Kinase C Product Introduction
1.2 Market Segments
1.3 Key Aurora Kinase C Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Aurora Kinase C Market Size Growth Rate by Type
1.4.2 AMG-900
1.4.3 Danusertib
1.4.4 Ilorasertib
1.4.5 NMI-900
1.4.6 SAR-156497
1.4.7 Others
1.5 Market by Application
1.5.1 Global Aurora Kinase C Market Size Growth Rate by Application
1.5.2 Solid Tumor
1.5.3 Non-Small Cell Lung Cancer
1.5.4 Acute Lymphocytic Leukemia
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Aurora Kinase C Market Size, Estimates and Forecasts
2.1.1 Global Aurora Kinase C Revenue 2015-2026
2.1.2 Global Aurora Kinase C Sales 2015-2026
2.2 Global Aurora Kinase C, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Aurora Kinase C Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Aurora Kinase C Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Aurora Kinase C Competitor Landscape by Players
3.1 Aurora Kinase C Sales by Manufacturers
3.1.1 Aurora Kinase C Sales by Manufacturers (2015-2020)
3.1.2 Aurora Kinase C Sales Market Share by Manufacturers (2015-2020)
3.2 Aurora Kinase C Revenue by Manufacturers
3.2.1 Aurora Kinase C Revenue by Manufacturers (2015-2020)
3.2.2 Aurora Kinase C Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Aurora Kinase C Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Aurora Kinase C Revenue in 2019
3.2.5 Global Aurora Kinase C Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Aurora Kinase C Price by Manufacturers
3.4 Aurora Kinase C Manufacturing Base Distribution, Product Types
3.4.1 Aurora Kinase C Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Aurora Kinase C Product Type
3.4.3 Date of International Manufacturers Enter into Aurora Kinase C Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Aurora Kinase C Market Size by Type (2015-2020)
4.1.1 Global Aurora Kinase C Sales by Type (2015-2020)
4.1.2 Global Aurora Kinase C Revenue by Type (2015-2020)
4.1.3 Aurora Kinase C Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Aurora Kinase C Market Size Forecast by Type (2021-2026)
4.2.1 Global Aurora Kinase C Sales Forecast by Type (2021-2026)
4.2.2 Global Aurora Kinase C Revenue Forecast by Type (2021-2026)
4.2.3 Aurora Kinase C Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Aurora Kinase C Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Aurora Kinase C Market Size by Application (2015-2020)
5.1.1 Global Aurora Kinase C Sales by Application (2015-2020)
5.1.2 Global Aurora Kinase C Revenue by Application (2015-2020)
5.1.3 Aurora Kinase C Price by Application (2015-2020)
5.2 Aurora Kinase C Market Size Forecast by Application (2021-2026)
5.2.1 Global Aurora Kinase C Sales Forecast by Application (2021-2026)
5.2.2 Global Aurora Kinase C Revenue Forecast by Application (2021-2026)
5.2.3 Global Aurora Kinase C Price Forecast by Application (2021-2026)

6 North America
6.1 North America Aurora Kinase C by Country
6.1.1 North America Aurora Kinase C Sales by Country
6.1.2 North America Aurora Kinase C Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Aurora Kinase C Market Facts & Figures by Type
6.3 North America Aurora Kinase C Market Facts & Figures by Application

7 Europe
7.1 Europe Aurora Kinase C by Country
7.1.1 Europe Aurora Kinase C Sales by Country
7.1.2 Europe Aurora Kinase C Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Aurora Kinase C Market Facts & Figures by Type
7.3 Europe Aurora Kinase C Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Aurora Kinase C by Region
8.1.1 Asia Pacific Aurora Kinase C Sales by Region
8.1.2 Asia Pacific Aurora Kinase C Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Aurora Kinase C Market Facts & Figures by Type
8.3 Asia Pacific Aurora Kinase C Market Facts & Figures by Application

9 Latin America
9.1 Latin America Aurora Kinase C by Country
9.1.1 Latin America Aurora Kinase C Sales by Country
9.1.2 Latin America Aurora Kinase C Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Aurora Kinase C Market Facts & Figures by Type
9.3 Central & South America Aurora Kinase C Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Aurora Kinase C by Country
10.1.1 Middle East and Africa Aurora Kinase C Sales by Country
10.1.2 Middle East and Africa Aurora Kinase C Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Aurora Kinase C Market Facts & Figures by Type
10.3 Middle East and Africa Aurora Kinase C Market Facts & Figures by Application

11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Aurora Kinase C Products Offered
11.1.5 AbbVie Inc Related Developments
11.2 Amgen Inc
11.2.1 Amgen Inc Corporation Information
11.2.2 Amgen Inc Description and Business Overview
11.2.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Inc Aurora Kinase C Products Offered
11.2.5 Amgen Inc Related Developments
11.3 Cielo Therapeutics Inc
11.3.1 Cielo Therapeutics Inc Corporation Information
11.3.2 Cielo Therapeutics Inc Description and Business Overview
11.3.3 Cielo Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cielo Therapeutics Inc Aurora Kinase C Products Offered
11.3.5 Cielo Therapeutics Inc Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Aurora Kinase C Products Offered
11.4.5 Sanofi Related Developments
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Aurora Kinase C Products Offered
11.1.5 AbbVie Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Aurora Kinase C Market Estimates and Projections by Region
12.1.1 Global Aurora Kinase C Sales Forecast by Regions 2021-2026
12.1.2 Global Aurora Kinase C Revenue Forecast by Regions 2021-2026
12.2 North America Aurora Kinase C Market Size Forecast (2021-2026)
12.2.1 North America: Aurora Kinase C Sales Forecast (2021-2026)
12.2.2 North America: Aurora Kinase C Revenue Forecast (2021-2026)
12.2.3 North America: Aurora Kinase C Market Size Forecast by Country (2021-2026)
12.3 Europe Aurora Kinase C Market Size Forecast (2021-2026)
12.3.1 Europe: Aurora Kinase C Sales Forecast (2021-2026)
12.3.2 Europe: Aurora Kinase C Revenue Forecast (2021-2026)
12.3.3 Europe: Aurora Kinase C Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Aurora Kinase C Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Aurora Kinase C Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Aurora Kinase C Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Aurora Kinase C Market Size Forecast by Region (2021-2026)
12.5 Latin America Aurora Kinase C Market Size Forecast (2021-2026)
12.5.1 Latin America: Aurora Kinase C Sales Forecast (2021-2026)
12.5.2 Latin America: Aurora Kinase C Revenue Forecast (2021-2026)
12.5.3 Latin America: Aurora Kinase C Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Aurora Kinase C Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Aurora Kinase C Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Aurora Kinase C Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Aurora Kinase C Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Aurora Kinase C Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Aurora Kinase C Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

AbbVie Inc、Amgen Inc、Cielo Therapeutics Inc、Sanofi

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のオーロラキナーゼC市場2026:インサイト・予測(Global Aurora Kinase C Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。